Oakley Capital is investing in ProductLife Group to accelerate its growth in the life sciences industry, aiming to triple its sales within five years.

Target Company Overview

ProductLife Group (PLG) is a prominent European provider of outsourced development, regulatory, and compliance services, specifically tailored to the global life sciences industry. The company's mission is to enhance patient access to safe and effective healthcare solutions by offering consulting and outsourcing services that span the entire product life cycle. With operations in over 150 countries, PLG acts as a strategic partner for organizations in the life sciences sector, facilitating the development, market introduction, and lifecycle management of various product portfolios.

Since being acquired by 21 Invest France in 2019, PLG has undergone significant transformation. The company has added new leadership, including the appointment of Xavier Duburcq as CEO in 2020, and has successfully executed 16 bolt-on acquisitions across 9 countries, enhancing its service offerings and geographical reach. As a result, ProductLife Group has achieved impressive growth, with sales reaching €167 million to date.

Industry Overview in the Life Sciences Sector

The life sciences industry in Europe is rapidly evolving, driven by technological advancements and an increasing emphasis on patient-centric solutions. Companies in this sector face a dynamic landscape characterized by regulatory complexities, c